@article{cbe7fa35fef3463baaf62d95001aaefc,
title = "First reported use of retrievable stent technology for removal of a large septic embolus in the middle cerebral artery",
abstract = "Background: The treatment of acute ischemic stroke in the setting of infective endocarditis (IE) is not well established. Although there have been a few reports on the use of intravenous thrombolysis, the role of mechanical thrombolysis through embolectomy is unknown. Case Description: A 78-year-old woman with an acute middle cerebral artery stroke secondary to septic embolization underwent successful stent retrieval of the septic embolus, followed by complete revascularization and neurologic improvement. Conclusions: Mechanical thrombolysis with embolectomy may be a safe and efficacious option for selected patients with acute ischemic stroke secondary to IE.",
keywords = "Acute ischemic stroke, Infective endocarditis, Mechanical embolectomy, Stent retrieval",
author = "Peter Kan and Sharon Webb and Siddiqui, {Adnan H.} and Levy, {Elad I.}",
note = "Funding Information: Conflict of interest statement: Dr. Levy receives research grant support (principal investigator: Stent-Assisted Recanalization in acute Ischemic Stroke), other research support (devices), and honoraria from Boston Scientific and research support from Codman & Shurtleff, Inc, and ev3/Covidien Vascular Therapies; has ownership interests in Intratech Medical Ltd and Mynx/Access Closure; serves as a consultant on the board of Scientific Advisors to Codman & Shurtleff, Inc; serves as a consultant per project or per hour for Codman & Shurtleff, Inc, ev3/Covidien Vascular Therapies, and TheraSyn Sensors, Inc; and receives fees for carotid stent training from Abbott Vascular and ev3/Covidien Vascular Therapies. Dr. Levy receives no consulting salary arrangements. All consulting is per project and/or per hour. Dr. Siddiqui has received research grants from the National Institutes of Health (coinvestigator: NINDS 1R01NS064592-01A1 ) and the University at Buffalo (Research Development Award); holds financial interests in Hotspur, Intratech Medical, StimSox, and Valor Medical; serves as a consultant to Codman & Shurtleff, Inc, Concentric Medical, ev3/Covidien Vascular Therapies, GuidePoint Global Consulting, and Penumbra; belongs to the speakers' bureaus of Codman & Shurtleff, Inc, and Genentech; serves on an advisory board for Codman & Shurtleff, Inc; and has received honoraria from Abbott Vascular, American Association of Neurological Surgeons' courses, an Emergency Medicine Conference, Genentech, Neocure Group LLC, and Abbott Vascular and Codman & Shurtleff, Inc, for training other neurointerventionists in carotid stent placement and for training physicians in endovascular stent placement for aneurysms. Dr. Siddiqui receives no consulting salary arrangements. All consulting is per project or per hour. Drs. Kan and Webb declare no commercial or financial relationships that could be construed as a potential conflict of interest. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2012",
doi = "10.1016/j.wneu.2011.05.059",
language = "English (US)",
volume = "77",
pages = "591.e1--591.e5",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "3-4",
}